Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGCETACOPLAN vs PEGFILGRASTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEGCETACOPLAN vs PEGFILGRASTIM: Safety Overview

Metric PEGCETACOPLAN PEGFILGRASTIM
Total FAERS Reports 1,369 80,974
Deaths Reported 84 2,367
Death Rate 6.1% 2.9%
Hospitalizations 252 7,050
Average Patient Age 65.4 yrs 61.2 yrs
% Female Patients 70.5% 66.3%
FDA Approval Date Feb 17, 2023 N/A
Manufacturer Apellis Pharmaceuticals, Inc. Sandoz Inc
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription